Ethics Sessions

Ethics Session Abstracts

The Great Debate: Drug Eluting Stents
Friday, March 28, 2003, 10:30 – 11:45 am
Speaker: Robert M. Califf, MD, FACC, Director

Focus on drug eluting stents as a new treatment option for coronary artery disease. Dr. Califf will describe the clinical trials and outcomes, both clinical and cost. The impact of the cost of drug eluting stents will be debated as well as the potential short and long term impacts on other treatment options. Work that is being conducted with CMS and the FDA related to drug eluting stents will be reviewed.

Healthcare Ratings and Their Impact
Friday, March 28, 2003, 1:00 – 2:15 pm
Speaker: Sarah Loughran, MBA, MHSA

Sponsored by Health Grades, Inc.

What are the implications of distribution of healthcare quality data? Organizations providing quality data include US News and World Report, HealthGrades, the Leapfrog Group, Solucient 100 Top, Consumers Checkbook, Subimo, and SelectQuality Care. What are the differences between these organizations? How do they rate hospitals? Find out how hospitals are using their good ratings to increase market share, recruit staff and build a quality reputation.

ValueShareâ„¢: The Approved Gainsharing Model
Friday, March 28, 2003, 2:45 – 4:00 pm
Speaker: Joane H. Goodroe, RN, MBA, FACCA

Sponsored by Goodroe Healthcare Solutions, Inc.

Goodroe Healthcare Solutions obtained the first positive ruling for hospital-physician gainsharing. A review of the approved model and current updates on the future of this important aspect of the overall management of healthcare services will be provided. Hospitals that have initiated this model will be discussed. Opportunities for all hospitals will be quantified. Ms. Goodroe will also give an update of changes being contemplated by Congress.

Heart Failure and the Need for Device Therapy
Saturday, March 29, 2002, 8:30 – 9:45 am
Speaker: William T. Abraham, MD, FAPC, FACC

Sponsored by Guidant Corporation

What are the ethical dilemmas regarding advanced therapies (cardiac transplantation and mechanical assistance) for the management of Stage D or end stage patient? Dr. Abraham will review the guidelines recently updated by ACC/AHA for evaluation and management of chronic heart failure. He will discuss staging heart failure patients according to disease progression to provide a framework for heart failure therapy.

Return to Sessions Main Page